Sands Capital Management LLC Has Boosted Its Position in Incyte Corp (INCY) by $130.93 Million as Stock Value Declined

June 14, 2018 - By Kristen Paramore

Incyte Corporation (NASDAQ:INCY) LogoInvestors sentiment increased to 1.22 in Q1 2018. Its up 0.16, from 1.06 in 2017Q4. It increased, as 45 investors sold INCY shares while 131 reduced holdings. 57 funds opened positions while 157 raised stakes. 190.28 million shares or 0.76% less from 191.73 million shares in 2017Q4 were reported. Clarivest Asset Mgmt Ltd Liability Corp invested in 4 shares or 0% of the stock. Loring Wolcott & Coolidge Fiduciary Advisors Ltd Liability Partnership Ma has invested 0% of its portfolio in Incyte Corporation (NASDAQ:INCY). C Worldwide Group Inc Holdg A S stated it has 0.05% in Incyte Corporation (NASDAQ:INCY). Ameritas Investment Partners stated it has 7,552 shares. Oak Ridge Invests holds 45,413 shares. Tekla Capital Management Ltd Llc, Massachusetts-based fund reported 645,442 shares. Great West Life Assurance Company Can accumulated 123,993 shares or 0.03% of the stock. Tirschwell & Loewy Incorporated accumulated 7,355 shares. Nippon Life Investors Americas has invested 1.21% of its portfolio in Incyte Corporation (NASDAQ:INCY). Massmutual Trust Fsb Adv stated it has 14 shares. The Florida-based State Board Of Administration Of Florida Retirement System has invested 0.06% in Incyte Corporation (NASDAQ:INCY). Commonwealth Savings Bank Of, Australia-based fund reported 69 shares. Zeke Cap Advisors Ltd Limited Liability Company invested 0.04% in Incyte Corporation (NASDAQ:INCY). The Montana-based Da Davidson has invested 0.02% in Incyte Corporation (NASDAQ:INCY). 17,842 were reported by Kbc Group Nv.

Since January 5, 2018, it had 1 insider purchase, and 4 selling transactions for $5.08 million activity. The insider Huber Reid M sold 1,958 shares worth $167,507. 1,952 shares were sold by GRYSKA DAVID W, worth $167,013 on Tuesday, February 20. Shares for $914,100 were bought by Hoppenot Herve.

Sands Capital Management Llc increased its stake in Incyte Corp (INCY) by 19.26% based on its latest 2018Q1 regulatory filing with the SEC. Sands Capital Management Llc bought 1.58 million shares as the company’s stock declined 21.82% with the market. The institutional investor held 9.77 million shares of the commercial physical & biological resarch company at the end of 2018Q1, valued at $814.03M, up from 8.19 million at the end of the previous reported quarter. Sands Capital Management Llc who had been investing in Incyte Corp for a number of months, seems to be bullish on the $15.63 billion market cap company. The stock increased 4.54% or $3.2 during the last trading session, reaching $73.74. About 2.37M shares traded. Incyte Corporation (NASDAQ:INCY) has declined 50.56% since June 14, 2017 and is downtrending. It has underperformed by 63.13% the S&P500.

Sands Capital Management Llc, which manages about $42.07 billion and $33.81B US Long portfolio, decreased its stake in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 478,927 shares to 7.25M shares, valued at $587.58 million in 2018Q1, according to the filing. It also reduced its holding in Netflix Inc (NASDAQ:NFLX) by 473,879 shares in the quarter, leaving it with 6.37M shares, and cut its stake in Alphabet Inc.

More important recent Incyte Corporation (NASDAQ:INCY) news were published by: which released: “Best And Worst Performing Nasdaq 100 Stocks Of 2018” on May 25, 2018, also published article titled: “Premarket analyst action – healthcare”, published: “3 Biotechs With Huge FDA Decisions in June” on May 31, 2018. More interesting news about Incyte Corporation (NASDAQ:INCY) was released by: and their article: “Incyte (INCY) Strength Tied to AbbVie’s (ABBV) M&A Comment – Bloomberg” with publication date: June 14, 2018.

Incyte Corporation (NASDAQ:INCY) Ratings Coverage

Among 16 analysts covering Incyte (NASDAQ:INCY), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Incyte had 21 analyst reports since January 2, 2018 according to SRatingsIntel. SunTrust maintained the shares of INCY in report on Monday, April 23 with “Buy” rating. RBC Capital Markets maintained it with “Buy” rating and $11400 target in Wednesday, April 4 report. BMO Capital Markets maintained Incyte Corporation (NASDAQ:INCY) rating on Tuesday, January 2. BMO Capital Markets has “Buy” rating and $172.0 target. The rating was downgraded by Guggenheim to “Neutral” on Friday, April 6. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, February 15 report. The rating was maintained by JP Morgan on Monday, April 9 with “Overweight”. The rating was downgraded by Gabelli to “Hold” on Monday, April 9. The stock has “Buy” rating by Raymond James on Thursday, February 15. The stock of Incyte Corporation (NASDAQ:INCY) earned “Hold” rating by Oppenheimer on Tuesday, May 1. The stock of Incyte Corporation (NASDAQ:INCY) has “Buy” rating given on Thursday, February 15 by RBC Capital Markets.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: